When combined with ABT-737, co-delivery NP led to consistently restrained Ki67 expression at day 50 (Fig. 5e; see low-magnification data in Supplementary Fig. 19), which corroborated the long-lasting tumor inhibition effect in Fig. 5d. Here, MKI67 is linked to neoplasm.